FAP-Targeted Fluorescent Imaging Agents to Study Cancer-Associated Fibroblasts In Vivo
Bioconjugate Chemistry · 15.01.2025 · 36 (1) · 44-53
DOI: 10.1021/acs.bioconjchem.4c00426 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioconjugate Chemistry, online erschienen am 12.12.2024. Verfasst von Riley J Deutsch-Williams und 6 weiteren Autor:innen. Beteiligte Einrichtung: Center for Systems Biology, Massachusetts General Hospital, 185 Cambridge Street, CPZN 5206, Boston, Massachusetts 02114, United States. Hauptthemen laut MEDLINE: Fluorescent Dyes, Gelatinases, Cancer-Associated Fibroblasts, Serine Endopeptidases. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, National Cancer Institute.
Abstract (Originalsprache)
Cancer-associated fibroblasts (CAFs) expressing fibroblast activation protein alpha (FAP) are abundant in tumor microenvironments and represent an emerging target for PET cancer imaging. While different quinolone-based small molecule agents have been developed for whole-body imaging, there is a scarcity of well-validated fluorescent small molecule imaging agents to better study these cells in vivo. Here, we report the synthesis and characterization of a series of fluorescent FAP imaging agents based on the common quinolone azide inhibitor. Our data show excellent performance of some synthesized FAP Targeting Fluorescent probes (FTFs) for both topical application and intravenous delivery to label CAF populations in solid tumors. These results suggest that FTF can be used to study CAF biology and therapeutic targeting in vivo.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Center for Systems Biology, Massachusetts General Hospital, 185 Cambridge Street, CPZN 5206, Boston, Massachusetts 02114, United States.
- Department of Systems Biology, Harvard Medical School, 200 Longwood Avenue, Boston, Massachusetts 02115, United States.
ORCID-Profile: Kelton A Schleyer, Rainer H Kohler, Ralph Weissleder
Förderung
- NCI NIH HHS
- National Cancer Institute
Zitieren
APA
Deutsch-Williams, R. J., Schleyer, K. A., Das, R., Carrothers, J. E., Kohler, R. H., Vinegoni, C., & Weissleder, R. (2025). FAP-Targeted Fluorescent Imaging Agents to Study Cancer-Associated Fibroblasts In Vivo. Bioconjugate Chemistry, 36(1), 44-53. https://doi.org/10.1021/acs.bioconjchem.4c00426
Vancouver
Deutsch-Williams RJ, Schleyer KA, Das R, Carrothers JE, Kohler RH, Vinegoni C, et al. FAP-Targeted Fluorescent Imaging Agents to Study Cancer-Associated Fibroblasts In Vivo. Bioconjugate Chemistry. 2025;36(1):44-53. doi:10.1021/acs.bioconjchem.4c00426
BibTeX
@article{DeutschWilliams2025,
author = {Deutsch-Williams, Riley J and Schleyer, Kelton A and Das, Riddha and Carrothers, Jasmine E and Kohler, Rainer H and Vinegoni, Claudio and Weissleder, Ralph},
title = {FAP-Targeted Fluorescent Imaging Agents to Study Cancer-Associated Fibroblasts In Vivo},
journal = {Bioconjugate Chemistry},
year = {2025},
volume = {36},
number = {1},
pages = {44--53},
doi = {10.1021/acs.bioconjchem.4c00426}
}
EUVIMED